The BSE benchmark index, the Sensex, fell nearly 1,500 points, or eight per cent, in the four trading sessions ending Wednesday. Stocks such as Dr Reddy's Laboratories fell seven per cent, Sun Pharmaceutical Industries 11 per cent, Cipla seven per cent, Tata Consultancy Services six per cent, Infosys four per cent and Wipro four per cent in the same period.
On Thursday, as the rupee touched a new low of Rs 65.56 against the dollar, these sectors were up about 2.5 per cent. Healthcare stocks have outperformed since the rupee began falling, dropping 1.5 per cent, compared with a four per cent decline in the Sensex. And this, after a correction from an eight per cent rise in the interim period. The BSE IT index has done one better, having risen by about 21 per cent.
Market participants say defensives such as health care and technology are favourites among investors, owing to the dollar exposure of the companies. Earnings numbers of these companies are expected to be better in the forthcoming second quarter due to the continued depreciation of the rupee.
"The US recovery is a good news for these companies. There are still some opportunities available as some of the companies in the large and mid-cap space are still reasonably valued," said Amish Munshi, senior fund manager and head of research-equities, Tata Asset Management.
Valuation issues could play spoil-sport, suggest some.
"In an uncertain environment like this, people like hiding in a defensive sector. However, some of these stocks are still not fairly valued," said Rikesh Parikh, vice-president-equities at Motilal Oswal Financial Services.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)